Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Cigna Corp (NY: CI )

319.77 +0.28 (+0.09%)
Official Closing Price Updated: 7:00 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,315,170
Open 319.69
Bid (Size) 312.45 (1)
Ask (Size) 321.00 (1)
Prev. Close 319.49
Today's Range 317.48 - 321.75
52wk Range 253.95 - 370.82
Shares Outstanding 340,107,539
Dividend Yield 1.54%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare
Trump's second term could bring significant changes to U.S. healthcare, with cuts to ACA subsidies and potential Medicare privatization. 
Via Benzinga
Topics Government
Exposures Political
3 Healthcare Stocks For Long-Term Growth And Dividends
Healthcare stocks will profit from the U.S. aging population and pay rising dividends over time. 
Via Talk Markets

Performance

YTD
+3.12%
+3.12%
1 Month
-8.77%
-8.77%
3 Month
-2.54%
-2.54%
6 Month
-8.41%
-8.41%
1 Year
+9.06%
+9.06%

More News

Read More
Boomer Benefits Unveils Revamped 6-Day Mini-Course on Medicare
Via Newsfile
Price Over Earnings Overview: Cigna
Via Benzinga
MarketBeat Week in Review – 10/28 - 11/1
Via MarketBeat
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Interest Rates
NYSE:CI is an undervalued gem with solid fundamentals.
Via Chartmill
Investors seeking growth at a reasonable cost should explore NYSE:CI.
Via Chartmill
Stocks Tumble, Nasdaq 100 Selloffs As Tech Giants Disappoint, Crypto Companies Plummet: What's Driving Markets Thursday?
Via Benzinga
Cigna Group (CI) Q3 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Cigna's Q3 Profit Beats Street On Strong Demand For Pharmacy Benefit Management's Specialty Drugs, New Clients
Via Benzinga
11 Analysts Assess Cigna: What You Need To Know
Via Benzinga
Here's How Much You Would Have Made Owning Cigna Stock In The Last 15 Years
Via Benzinga
$100 Invested In This Stock 15 Years Ago Would Be Worth $1,200 Today
Via Benzinga
The Cigna Group Reports $63.7 Billion In Q3 Total Revenues, Better Than Expected
Via Talk Markets
Cigna Considers Humana Acquisition – What It Means for the Stocks
Via MarketBeat
Jim Cramer: Buy Broadcom, But Stay Away From These Stocks
Via Benzinga
Why Cigna Group Stock Got Mashed on Monday
Via The Motley Fool
Stocks Fall As Treasury Yields, Dollar Rise; Nvidia Hits Record Highs: What's Driving Markets Monday?
Via Benzinga
Cigna And Humana Revive Early Merger Talks After Year-Long Pause As Medicare Cost Pressure Looms
Via Benzinga
Cigna-Humana Merger Talks Back On With Tables Turned; 2024 Election Is Key
Via Investor's Business Daily
Market Briefing For Monday, Oct 21
Via Talk Markets
SAP, Nucor And 3 Stocks To Watch Heading Into Monday
Via Benzinga
Pharmacy Retailer CVS Health Backs Away From Annual Forecast, Names New CEO
Via Benzinga
CVS, UnitedHealth Request FTC Chair Recusal Amid Ongoing Pharmacy Benefit Managers Lawsuit
Via Benzinga
3 Dividend Growth Stocks Set to Supercharge Your Portfolio
Via MarketBeat
Topics ETFs
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.